(Reuters) – Evolus said on Thursday the U.S. Food and Drug Administration has approved its two new anti-wrinkle injectable gels, expanding the company’s product portfolio beyond its cosmetic injection Jeuveau.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
Comments